27th Sep 2011 07:00
Press Release | 27 September 2011 |
Syntopix Group plc
("Syntopix", "the Company")
Posting of Circular and Notice of General Meeting
Syntopix Group plc (AIM:SYN), the dermatological experts delivering healthcare innovation to the cosmetic, consumer healthcare and pharmaceutical industries, today announces that a Circular containing details of a proposed change of name of the Company from Syntopix Group plc to Evocutis plc, including the Notice of the General Meeting, was posted to shareholders on 26 September 2011. The General Meeting will be held at 1.00pm on 20 October 2011 at the offices of IP Group plc, 24 Cornhill, London, EC3V 3ND.
Copies of the Circular, including the Notice of General Meeting will be available on the Company's website, www.syntopix.com and from the registered office, Leeds Skin Building, Sandbeck Lane, Wetherby, LS22 7TW.
- Ends -
For further information, please contact:
Syntopix Group plc | |
Dr Stephen Jones, Chief Executive Officer | +44 (0)845 125 9204 |
Tom Bannatyne, Chairman | www.syntopix.com |
Zeus Capital Ltd | |
Tom Rowley | Tel: +44(0)161 831 1512 |
www.zeuscapital.co.uk |
XCAP Securities Plc | |
Karen Kelly/Jon Belliss/Parimal Kumar | Tel: +44(0) 207 101 7070 |
www.xcapgroup.co.uk |
Media enquiries:
Abchurch Communications | |
Sarah Hollins/Adam Michael/ Jamie Hooper | Tel: +44 (0) 20 7398 7708 |
www.abchurch-group.com |
Related Shares:
Gunsynd